|
03/10/2010 04:00 AM
|
|
Link Between Obesity And Poor Colon Cancer Prognosis
|
Obese patients with colon cancer are at greater risk for death or recurrent disease compared to those who are within a normal weight range, according to a report in Clinical Cancer Research, a journal of the American Association for Cancer Research...
|
|
03/10/2010 02:00 AM
|
|
Cellectar Completes Enrollment In Phase I Clinical Trial Of Lead Drug Candidate (131)I-CLR1404 For The Treatment Of Solid Malignancies
|
Cellectar, Inc., a privately held radiopharmaceutical company that designs and develops products to detect, treat and monitor human cancers, announced that enrollment for its Phase I dosimetry trial for its lead drug candidate, (131)I-CLR1404 has been completed. Results of this trial will be used to set the starting dose in a follow-on Phase I dose escalation study planned for later this year...
|
|
03/10/2010 02:00 AM
|
|
TechniScan Teams With Researchers At UC San Diego In Clinical Study With Warm Bath Ultrasound(TM) System
|
TechniScan, Inc. (OTC Bulletin Board: TSNI) ("TechniScan" or the "Company"), a medical device company engaged in the development and commercialization of an automated breast ultrasound imaging system, announced that it has commenced phase two of its grant study at the University of California, San Diego (UCSD) Moores Cancer Center...
|
|
03/10/2010 02:00 AM
|
|
Intentional Variation Increases Result Validity In Mouse Testing
|
For decades, the traditional practice in animal testing has been standardization, but a study involving Purdue University has shown that adding as few as two controlled environmental variables to preclinical mice tests can greatly reduce costly false positives, the number of animals needed for testing and the cost of pharmaceutical trials...
|
|
03/10/2010 02:00 AM
|
|
Massage Eases Anxiety, But No Better Than Simple Relaxation Does
|
A new randomized trial shows that on average, three months after receiving a series of 10 massage sessions, patients had half the symptoms of anxiety. This improvement resembles that previously reported with psychotherapy, medications, or both...
|
|
03/10/2010 01:00 AM
|
|
When Personality Makes Drugs Ineffective In Depression
|
A study published in the current issue of Psychotherapy and Psychosomatics addresses the role of personality factors in moderating treatment response in depression...
|
|
03/10/2010 01:00 AM
|
|
First Time Research On Long-term Consequences Of Intravenous Nutrition On Children's Health
|
No work is known in the literature to date which provides a long-term and generalised evaluation of the health of children fed intravenously in their own home...
|
|
|
• Home
• FDA News
• Medicines
• Cancer
• Heart Disease
• Articles
|
|
03/10/2010 09:50 AM
|
|
WinRho SDF (Rho(D) Immune Globulin Intravenous (Human): Risk of Intravascular Hemolysis
|
Cases of intravascular hemolysis and its complications have been reported in patients treated for immune thrombocytopenic purpura with WinRho.
|
|
03/08/2010 11:15 AM
|
|
Cardiac Science Automated External Defibrillators (Powerheart, Cardiovive, CardioLife, NK, Responder models): Class I Recall
|
UPDATED 03/08/2010: Recall classified as Class I, expanded list of affected models. Originally posted 02/09/2010
|
|
03/05/2010 09:20 AM
|
|
Thomas Medical Products, Inc., Transseptal Sheath Introducer Kits: Class I Recall
|
Sheath tip may break off and separate during heart procedures, causing a blockage that could lead to permanent injury and/or death.
|
|
03/03/2010 08:55 AM
|
|
Baxter HomeChoice and HomeChoice PRO Automated Peritoneal Dialysis Systems: Class I Recall
|
Reports of serious injuries and at least one death have been associated with increased Intraperitoneal Volume (IIPV), also known as overfill of the abdominal cavity.
|
|
02/26/2010 02:05 PM
|
|
OneTouch SureStep Test Strips (LifeScan): Recall
|
Test strips are being recalled because they may provide falsely low glucose results when the glucose level is higher than 400 mg/dL.
|
|
02/26/2010 11:05 AM
|
|
StatSpin Express 4 Centrifuges Model 510: Class I Recall
|
Rotor may break and eject pieces of the rotor which may cause serious physical injury to bystanders and expose them to blood-borne infectious micro-organisms.
|
|
02/23/2010 10:32 AM
|
|
Invirase (saquinavir): Ongoing safety review of clinical trial data
|
Possible association with abnormal heart rhythms when used in combination with Norvir (ritonavir).
|
|
02/22/2010 12:00 PM
|
|
Avandia (rosiglitazone): Ongoing Review of Cardiovascular Safety
|
FDA is reviewing data from a large, long-term clinical study on possible risks for cardiovascular outcomes associated with use of rosiglitazone.
|
|
02/20/2010 01:15 PM
|
|
Ear Candles: Risk of Serious Injuries
|
Consumers warned not to use ear candles because they can cause serious injuries, even when used according to the manufacturer’s directions.
|
|
02/18/2010 12:20 PM
|
|
Long-Acting Beta-Agonists (LABAs): New Safe Use Requirements
|
FDA requires risk management plan and class-labeling changes for all LABAs.
|
|
|